logo
Why PepsiCo, Inc. (PEP) is the Best Packaged Food Stock to Buy Now

Why PepsiCo, Inc. (PEP) is the Best Packaged Food Stock to Buy Now

Yahoo14-04-2025

We recently published a list of . In this article, we are going to take a look at where PepsiCo, Inc. (NASDAQ:PEP) stands against other best packaged food stocks to buy now.
According to a report by Grand View Research, the US packaged food market had a size of $1.03 trillion in 2021. It is expected to grow at a compound annual growth rate (CAGR) of 4.8% between 2022 and 2030. The primary growth drivers for the industry include the rising consumer inclination for convenience coupled with consumers' hectic lives and work schedules. In addition, the rise in e-commerce sales in the US is another significant factor supporting the sale of packaged food nationwide. Growing innovation in plant-based products, food packaging, healthy ingredients, and bold flavors is expected to continue driving this growth in the United States in the coming years.
READ ALSO: and .
On April 8, BofA Securities analysts Bryan D. Spillane, Lisa K. Lewandowski, and Peter T. Galbo released their research findings on the consumer staples industry and their expected performance in case of a potential recession. The analysts iterated that in a majority of recent recessions, consumer staples have historically outperformed the S&P 500 as a sector. This trend points towards a defensive edge for the sector. However, the analysts also cautioned that current market conditions, including weak volume growth and lingering high prices, should be considered, as they may affect the sector's resilience in a future downturn. Despite these concerns, consumer staples make up an appealing sector for investors and experts due to their limited exposure to the recently imposed tariffs, potentially helping sustain valuation multiples.
During recessions, the stock prices in the consumer staples sector are typically affected by earnings per share (EPS) instead of sales growth. Yahoo! Finance reported that sector analysis highlights forward EPS accounting for more than 90% of stock price movement across central subsectors, including Packaged Food, Beverages, Household and Personal Care, and Tobacco. The analysts also opined that these trends reflect the significance of earnings strength when determining stock performance in volatile and uncertain economic conditions.
Yahoo! Finance further reported that the top-performing stocks in the consumer staples sector are likely to share three common traits. These include solid balance sheets with the potential to sustain share buybacks to boost EPS, profit flexibility to offset increasing costs and revenue pressure, and a strong manufacturing presence in the US to constrain tariff-related inflation.
We sifted through stock screeners, financial media reports, and ETFs to compile a list of 30 packaged food stocks and chose the top 10 most popular among hedge funds as of Q4 2024. The list is ordered in ascending order of hedge fund sentiment. We sourced the hedge fund sentiment data from Insider Monkey's database.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A close up of a glass of a refreshing carbonated beverage illustrating the company's different beverages.PepsiCo, Inc. (NASDAQ:PEP) manufactures, markets, distributes, and sells packaged food, snacks, and beverages. The company operates in the following segments: Frito-Lay North America (FLNA), Quaker Foods North America (QFNA), PepsiCo Beverages North America (PBNA), Latin America (LatAm), Europe, Africa, Middle East, and South Asia (AMESA), and Asia Pacific, Australia and New Zealand, and China Region (APAC).
PepsiCo, Inc. (NASDAQ:PEP) has a strong cash position and generated $12.5 billion in operating cash flow during fiscal year 2024. Operating profit rose from $11.9 billion in fiscal year 2023 to $12.8 billion, while net income improved by reaching $9.6 billion. The company also maintained steady revenue of $91.8 billion, a slight increase from last year. It plans to return approximately $7.6 billion to shareholders this fiscal year through dividend payments.
For 2025, PepsiCo, Inc. (NASDAQ:PEP) expects low-single-digit organic revenue growth and mid-single-digit growth in core constant currency earnings per share (EPS).
Overall, PEP ranks 1st on our list of best packaged food stocks to buy now. While we acknowledge the potential for PEP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than PEP but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

From Chandelier to Cube: The Versatile Forms of 6:AM's '▢ [quadrato]' Collection
From Chandelier to Cube: The Versatile Forms of 6:AM's '▢ [quadrato]' Collection

Hypebeast

time38 minutes ago

  • Hypebeast

From Chandelier to Cube: The Versatile Forms of 6:AM's '▢ [quadrato]' Collection

Summary 6:AM Glassworkshas recently unveiled its new '▢ [quadrato]' collection, a visual statement that reinterprets Murano-blown glass through essential lines and geometric forms. This innovative series draws inspiration from the industrial lamps of the 1920s, blending the rational language of the Bauhaus movement with the minimalist aesthetic championed by Malevich. The resulting collection spotlights modular lighting pieces, where intricate details, such as air bubbles, grooves and transparencies, contribute to each product's unique narrative. ' ▢ [quadrato]' was debuted during this year'sMilan Design Week, where it was featured within theTwo-Fold Silenceexhibition held at Piscina Cozzi — a historic former public bath. This setting provided a unique immersion into the brand's creative universe, allowing visitors to experience the interplay of rationality and instinct, as well as form and intuition that define the collection. The collection offers a versatile range of lighting solutions, available in suspension, wall, table, and floor variations. A notable piece within the collection is the ▢ [EXIT], which features screen-printed lattimo glass and a painted iron structure. Inspired by emergency lamps from the '20s, its pattern replicates pre-plastic designs, blending functionality with artistic craftsmanship in a striking red and white palette. Another standout piece worth mentioning is the ▢ [quadrato 36], a contemporary reinterpretation of the classic chandelier. This striking installation, composed of 36 hand-blown glass cubes, recalls the purity of Bauhaus aesthetics. Its planar arrangement emphasizes geometric precision, forming a floating grid of illuminated cubes that can be inquired about upon request. Crafted from lattimo handblown glass and powder-coated iron, the '▢ [quadrato] collection' exemplifies 6:AM's commitment to transforming functional objects into aesthetic and architectural pieces. Prices vary between €900 – €5,200 EUR (approx $1,035 – $5,978 USD) across the collection, with the exception of ▢ [quadrato 3 being available upon request. For more information, head over to 6:30's officialwebsite.

Prime Success Responds to Sinovac Biotech's False and Misleading Claims
Prime Success Responds to Sinovac Biotech's False and Misleading Claims

Business Wire

timean hour ago

  • Business Wire

Prime Success Responds to Sinovac Biotech's False and Misleading Claims

HONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, 'Prime Success' or 'we'), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) ('Sinovac' or the 'Company') with ownership of approximately 8% of the Company's outstanding shares, today issued the following letter in response to the Company's recent false and misleading claims relating to the upcoming Special Meeting of Shareholders (the 'Special Meeting') scheduled for July 8, 2025. The full text of the letter is below and available at Dear fellow Sinovac shareholders, Prime Success, L.P. (together with its affiliates, 'Prime Success' or 'we'), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) ('Sinovac' or the 'Company'), continues to be disappointed by the current Board's ('1Globe Activist Board') distortion of the facts about what is at stake at the upcoming Special Meeting of Shareholders (the 'Special Meeting') scheduled for July 8, 2025. In our June 10 letter we addressed several of the 1Globe Activist Board's misstatements and are taking the opportunity to remind all shareholders why the 1Globe Activist Board cannot be trusted: 1. Prime Success is insisting that a dividend be distributed – for all shareholders The 1Globe Activist Board's false comments are just not credible – why would any investor be against receiving a dividend? The 1Globe Activist Board wants you to believe that Prime Success is the reason that dividends have not been distributed, but we are not the Company and are not on the Board, and dividend distribution decisions are not ours to make. We can only continue to advocate on behalf of all shareholders that they should be made. Under the leadership of a SAIF Partners IV L.P. ('SAIF') nominated Board — composed of seasoned professionals with proven governance experience, deep operational insight, and a track record of building real, lasting value — we are confident that the pattern of internal conflict and ongoing litigation fueled by the 1Globe Activist Board can be broken, and shareholders can look forward to more future dividends. But that will not be possible with the 1Globe Activist Board in power as they have made clear they prioritize endless litigation over the Company's long-term success. 2. The 1Globe Activist Board is deliberately baiting shareholders by setting the dividend distribution date for one day after the Special Meeting. We call upon the Company to make dividend distribution before the Special Meeting The 1Globe Activist Board deliberately set the dividend date for one day after the Special Meeting which creates the false impression that shareholders must vote for the incumbents to receive the dividends. But the upcoming Special Meeting will determine the Company's future direction and the long-term interests of all shareholders. We call on the 1Globe Activist Board to allow for a fair, pro rata distribution of dividends and to move the date of the dividend distribution to before the Special Meeting so the meeting can refocus on its proper purpose: electing a competent Board. 3. The 1Globe Activist Board distorts historic facts to aggrandize 1Globe and smear legitimate investors Let's compare facts against rhetoric of the 1Globe Activist Board. Over the past seven years, what have we contributed to the Company? The critical lifeline investments from Prime Success and Vivo Capital, LLC, combined with management's determined efforts, enabled Sinovac to seize a pivotal opportunity: the development of CoronaVac. This initiative ultimately resulted in the delivery of billions of doses to over 60 countries, generating substantial revenues while saving countless lives. Without the success of CoronaVac, there would not be any sizable dividend to distribute now. In contrast, what has 1Globe done for the Company? It has initiated multi-jurisdictional litigation against Sinovac, leading to a waste of company resources. The 1Globe Activist Board's mischaracterization of 1Globe and Prime Success' relative contribution to Sinovac and its shareholders reveals its deeply partisan nature. 4. Shareholders: looking forward, it's time to focus on what truly matters – the future of your investment in Sinovac Sinovac needs a Board that will roll up its sleeves and run the business, guiding the Company forward on a stable, productive path. The slate put forward by SAIF, consisting of representatives from all shareholders owning more than 5% of the Company's equity stake, many of whom possess deep industry experience, achieves exactly that. We urge all shareholders to focus on the future and choose the leadership that will best secure our Company's success in the years to come. We look forward to continuing to make our case for change to our fellow shareholders and encourage them to wait for and read SAIF's proxy materials before voting for the Special Meeting on July 8, 2025. Sincerely, Prime Success, L.P. About Prime Success, L.P. Prime Success is an investment vehicle established by Advantech Capital specifically to invest in Sinovac and Sinovac Life Sciences; Advantech Capital is a private equity fund established in 2016 with a focus on innovation-driven growth opportunities in China.

Analysts shows confidence in S&P entrant, raising target by 15%
Analysts shows confidence in S&P entrant, raising target by 15%

Yahoo

timean hour ago

  • Yahoo

Analysts shows confidence in S&P entrant, raising target by 15%

Analysts shows confidence in S&P entrant, raising target by 15% originally appeared on TheStreet. The analysts at Cantor Fitzgerald have raised their 12-month price target for Coinbase (Nasdaq: COIN) from $253 to $292. Founded in 2012, Coinbase is the largest crypto exchange in the U.S. that went public in April 2021. Last month, it emerged as the first public crypto company to earn a spot on the S&P 500 index. Cantor Fitzgerald analysts led by Brett Knoblauch wrote in a recent note to clients that over the long term, Coinbase's trading activities will allow it to increase its market share and its activities outside of trading will materially alter "how investors view COIN." Though the analysts at Cantor lowered their revenue estimates for the crypto exchange by nearly 4%, they doubled down on an "overweight" rating on COIN. The note also mentions that the analysts don't expect "material upside" from these new products this year, but there could be a "profound" shift in investor perception by the second half of 2026 and into 2027. During the company's 2025 State of Crypto Summit, it announced on 12 June a partnership with Shopify to help merchants accept payments in USDC, a stablecoin issued by Circle (NYSE: CRCL). The service is available to early access merchants at Shopify and will expand to stores across the globe running Shopify Payments later this year. The exchange also launched a credit card the same day. Called the Coinbase One Card, it claims to give users a chance to earn up to 4% in Bitcoin rewards on every purchase. The COIN stock closed at $242.71 on 13 June as the Israel-Iran conflict shook the markets. Analysts shows confidence in S&P entrant, raising target by 15% first appeared on TheStreet on Jun 13, 2025 This story was originally reported by TheStreet on Jun 13, 2025, where it first appeared.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store